WHO signs off on IL-6 drugs to treat severe Covid-19 cases, reigniting pricing debate

The World Health Organization has recommended its first new class of drugs to treat Covid-19 since it OK’ed corticosteroids back in September 2020, and the news will likely prove a boon for two major European drugmakers.